What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report the results of a deferred vote for the election of five members to CME Group's Class B-3 Nominating Committee, which took place on June 13, 2012.

Who are the Class B-3 shareholders, and why is this committee important?

The filing indicates that the Class B-3 Nominating Committee members are elected by Class B-3 shareholders. While the exact nature of Class B-3 shares and their specific rights are not detailed in this 8-K, nominating committees play a crucial role in corporate governance by recommending director candidates and overseeing governance practices. Therefore, their election is a matter of interest to shareholders concerned with the company's leadership and governance.

Does this filing contain any new financial information or strategic updates for CME Group?

No, this 8-K filing does not contain any new financial information, operational updates, or strategic business decisions from CME Group. It exclusively reports on the outcome of a specific shareholder vote related to corporate governance.

Where can I find the results of the deferred vote?

The detailed results, including votes for, against, and abstentions for each of the ten nominees for the Class B-3 Nominating Committee, are presented within the body of this 8-K filing.

CME 8-K: Shareholder Matters

Summary

This 8-K filing from CME Group Inc. reports on the results of a deferred vote for the election of five members to its Class B-3 Nominating Committee. This election, originally scheduled for the Annual Meeting on May 23, 2012, was postponed to June 13, 2012, and the results are now being disclosed. While not a strategic or financial update, this filing provides transparency on corporate governance matters, specifically concerning the shareholder election process for committee members. Investors interested in CME Group's governance structure and shareholder engagement should note the detailed voting results provided for each nominee. The filing includes the number of votes cast for, against, and abstentions for each of the ten nominees. This information is relevant for understanding the shareholder base's preferences regarding committee composition and can offer insights into the influence of Class B-3 shareholders.

Key Highlights

1CME Group Inc. filed an 8-K to report the results of a deferred shareholder vote.
2The vote was for the election of five members to the Class B-3 Nominating Committee.
3The election was originally part of the Annual Meeting on May 23, 2012, but was deferred to June 13, 2012.
4Detailed voting results (Votes For, Votes Against, Abstentions) are provided for ten nominees.
5The elected members will serve until 2013.
6This filing pertains to corporate governance and shareholder voting procedures.

CME GROUP INC. 8-K Report, Shareholder Vote Results (Jun 19, 2012)

Summary

Key Highlights

Frequently Asked Questions